Metraipolis › archive › dc_8496e413db11
Responsible Adoption of Artificial Intelligence (AI) in Pharmacy Practice: Perspectives of Regulators in Canada and the United States — Europe PMC PMID:41283613
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41283613
- DOI
- 10.3390/pharmacy13060152
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T09:15:58.541Z
- SHA-256 of the archived text
a6ff20f085b27c01f7ed23b611ad45c56c7c0c86d3eabfd71639b92ede185ae0- Stable URL of this page
https://metraipolis.com/documento/dc_8496e413db11
How to cite
Responsible Adoption of Artificial Intelligence (AI) in Pharmacy Practice: Perspectives of Regulators in Canada and the United States — Europe PMC PMID:41283613 — Europe PMC (en), https://europepmc.org/article/MED/41283613 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8496e413db11 (Metraipolis archive dc_8496e413db11, sha256 a6ff20f085b27c01f7ed23b611ad45c56c7c0c86d3eabfd71639b92ede185ae0)
BibTeX
@misc{dc8496e413db11,
title = {Responsible Adoption of Artificial Intelligence (AI) in Pharmacy Practice: Perspectives of Regulators in Canada and the United States — Europe PMC PMID:41283613},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41283613},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8496e413db11; sha256 a6ff20f085b27c01f7ed23b611ad45c56c7c0c86d3eabfd71639b92ede185ae0},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41283613. Agents can read the archived copy with the MCP tool read_document.